Europe Custom Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Service (Antibody Development, Antibody Production and Purification, and Antibody Fragmentation and Labelling); Type (Monoclonal Antibodies, Polyclonal Antibodies, and Other Custom Antibodies); Source (Mice, Rabbits, and Others); Research Area (Oncology, Immunology, Stem Cells, Infectious Diseases, Neurobiology, Cardiovascular Diseases, and Others); End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Contract Research Organizations)

Publication Month: Jul 2021 | Report Code: TIPRE00023710 | No. of Pages: 177 | Category: Pharmaceuticals | Status: Published

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The custom antibody market in Europe is expected to grow from US$ 102.5 million in 2021 to US$ 213.7 million by 2028; it is estimated to grow at a CAGR of 11.1% from 2021 to 2028. Biotechnology companies have been prominently focusing on collaborations, partnerships, acquisitions, and financial aids or funding for making progress in the markets they serve. Moreover, the COVID-19 pandemic has served opportunities to players to make some important strategic decisions. Following are a few instances of market consolidations that has leveraged growth of custom antibodies market. In January 2021, Morphic Therapeutic, a biotechnology company, collaborated with Janssen Pharmaceutical, Inc., a part of Johnson & Johnson Private Limited, to develop novel antibodies against third integrin target proteins (a family of ubiquitous receptors). Moreover, in July 2020, Cancer Research UK collaborated with Abcam, a life science reagents and tools developer, for the development of custom antibodies to enhance of cancer research and commercialize novel therapies. In January 2020, Abcam acquired Applied StemCell’s gene editing platform and oncology product portfolio, with an aim to strengthen its validation initiative for antibody quality control.

Countries in the European regions were profoundly affected due to the COVID-19 pandemic. For instance, countries such as Italy, Spain, and France have reported the highest number of positive cases and have registered the maximum number of deaths. Several companies have experienced severe losses in the last quarter of 2019; they have also negatively influenced the first and second quarters of 2020. Hence, the impact of COVID 19 on the European market was immediate and drastic. The custom antibody supply chain, which is already logistically complicated, has to face new challenges. The custom antibody market has also witnessed some shortfall at the beginning of the COVID 19 crisis due to disruption in supply chain and demand due to lockdown announced by most European countries. This result may last till the end of 2020 as most of the market players in Europe yet to adopt the novel diagnostic tests for COVID 19. However, in the extended period, the requirement for custom antibodies is expected to increase due to supportive government initiatives. For instance, in May 2020, ProteoGenix launched the first Human Immune COVID-19 library for the fast development of potent antibodies against SARS-CoV-2. Hence, the European custom antibody market will likely show significant growth prospects during this pandemic and forecasted year. Therefore, the preference for adopting custom antibody provides a favorable environment for the growth of the Europe custom antibody market during the forecast period.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the custom antibody market. The Europe Custom antibody market is expected to grow at a good CAGR during the forecast period.

Europe Custom antibody market

Get more information on this report :

Europe Custom Antibody Market Segmentation    

By Service

  • Antibody Development
  • Antibody Production and Purification
  • Antibody Fragmentation and Labelling

By Type

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Other Custom Antibodies

By Source

  • Mice
  • Rabbits
  • Others

By Research Area

  • Oncology
  • Immunology
  • Stem Cells
  • Infectious Diseases
  • Neurobiology
  • Cardiovascular Diseases
  • Others

By End User

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations 

By Country

  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Bio-Rad Laboratories Inc.
  • Merck KGAA
  • Abcam
  • Genscript
  • Agilent Technologies, Inc.
  • Cell Signaling Technology, Inc.

 

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Custom Antibody Market – By Service

1.3.2        Custom Antibody Market – By Type

1.3.3        Custom Antibody Market – By Source

1.3.4        Custom Antibody Market – By Research Area

1.3.5        Custom Antibody Market – By End User

1.3.6        Europe Custom Antibody Market – By Country

2.           Europe Custom Antibody Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Custom Antibody Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Custom Antibody Market- Europe PEST Analysis

4.3         Expert Opinion

5.           Europe Custom Antibody Market - Key Market Dynamics

5.1         Market Drivers

5.1.1        High Demand in Research

5.1.2        Market Consolidations Strategies Adopted by Biotechnology Companies

5.1.3        Production and Development Services Offered by Custom Antibody Providers

5.2         Market Restraints

5.2.1        High Cost of Production

5.3         Future Trends

5.3.1        Developments for Custom Antibodies

5.4         Impact Analysis

6.           Custom Antibody Market – Europe Analysis

6.1         Europe Custom Antibody Market Revenue Forecasts and Analysis

7.           Europe Custom Antibody Market Analysis and Forecasts To 2028 – By Service

7.1         Overview

7.2         Custom Antibody Market Revenue Share, by Service (2020 and 2028)

7.3         Antibody Development

7.3.1        Overview

7.3.2        Antibody Development: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)

7.4         Antibody Production and Purification

7.4.1        Overview

7.4.2        Antibody Production and Purification: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)

7.5         Antibody Fragmentation and Labelling

7.5.1        Overview

7.5.2        Antibody Fragmentation and Labelling: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)

8.           Europe Custom Antibody Market Analysis and Forecasts To 2028 – By Type

8.1         Overview

8.2         Custom Antibody Market Revenue Share, by Type (2020 and 2028)

8.3         Monoclonal Antibodies

8.3.1        Overview

8.3.2        Monoclonal Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)

8.4         Polyclonal Antibodies

8.4.1        Overview

8.4.2        Polyclonal Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)

8.5         Other Custom Antibodies

8.5.1        Overview

8.5.2        Other Custom Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)

9.           Europe Custom Antibody Market Analysis and Forecasts To 2028 – By Source

9.1         Overview

9.2         Custom Antibody Market Revenue Share, By Source (2020 and 2028)

9.3         Mice

9.3.1        Overview

9.3.2        Mice: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Rabbit

9.4.1        Overview

9.4.2        Rabbit: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Others

9.5.1        Overview

9.5.2        Others: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

10.        Europe Custom Antibody Market Analysis and Forecasts to 2028– By Research Area

10.1      Overview

10.2      Custom Antibody Market Revenue Share, by Research Area (2020 and 2028)

10.3      Oncology

10.3.1     Overview

10.3.2     Oncology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Immunology

10.4.1     Overview

10.4.2     Immunology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

10.5      Stem Cells

10.5.1     Overview

10.5.2     Stem Cells: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

10.6      Infectious Disease

10.6.1     Overview

10.6.2     Infectious Disease: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

10.7      Neurobiology

10.7.1     Overview

10.7.2     Neurobiology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

10.8      Cardiovascular Disease

10.8.1     Overview

10.8.2     Cardiovascular disease: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

10.9      Others

10.9.1     Overview

10.9.2     Others: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

11.        Europe Custom Antibody Market Analysis and Forecasts to 2028– By End User

11.1      Overview

11.2      Custom Antibody Market Revenue Share, by End User (2020 and 2028)

11.3      Pharmaceutical and Biotechnology Companies

11.3.1     Overview

11.3.2     Pharmaceutical and Biotechnology Companies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)

11.4      Academic and Research Institutes

11.4.1     Overview

11.4.2     Academic and Research Institutes: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)

11.5      Contract Research Organizations

11.5.1     Overview

11.5.2     Contract Research Organizations: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)

12.        Custom Antibody Market Revenue and Forecasts to 2028 – Geographical Analysis

12.1      Europe: Custom Antibody Market

12.1.1     Overview

12.1.2     Europe: Custom Antibody Market, by Country, 2020 & 2028 (%)

12.1.2.1       UK: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.1.1       UK: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.1.2       UK: Custom Antibody Market, by Service, 2019–2028 (USD Million)

12.1.2.1.3       UK: Custom Antibody Market, by Type, 2019–2028 (USD Million)

12.1.2.1.4       UK: Custom Antibody Market, by Source, 2019–2028 (USD Million)

12.1.2.1.5       UK: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)

12.1.2.1.6       UK: Custom Antibody Market, by End User, 2019–2028 (USD Million)

12.1.2.2       Germany: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.2.1       Germany: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.2.2       Germany: Custom Antibody Market, by Service, 2019–2028 (USD Million)

12.1.2.2.3       Germany: Custom Antibody Market, by Type, 2019–2028 (USD Million)

12.1.2.2.4       Germany: Custom Antibody Market, by Source, 2019–2028 (USD Million)

12.1.2.2.5       Germany: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)

12.1.2.2.6       Germany: Custom Antibody Market, by End User, 2019–2028 (USD Million)

12.1.2.3       France: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.3.1       France: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.3.2       France: Custom Antibody Market, by Service, 2019–2028 (USD Million)

12.1.2.3.3       France: Custom Antibody Market, by Type, 2019–2028 (USD Million)

12.1.2.3.4       France: Custom Antibody Market, by Source, 2019–2028 (USD Million)

12.1.2.3.5       France: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)

12.1.2.3.6       France: Custom Antibody Market, by End User, 2019–2028 (USD Million)

12.1.2.4       Italy: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.4.1       Italy: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.4.2       Italy: Custom Antibody Market, by Service, 2019–2028 (USD Million)

12.1.2.4.3       Italy: Custom Antibody Market, by Type, 2019–2028 (USD Million)

12.1.2.4.4       Italy: Custom Antibody Market, by Source, 2019–2028 (USD Million)

12.1.2.4.5       Italy: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)

12.1.2.4.6       Italy: Custom Antibody Market, by End User, 2019–2028 (USD Million)

12.1.2.5       Spain: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.5.1       Spain: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.5.2       Spain: Custom Antibody Market, by Service, 2019–2028 (USD Million)

12.1.2.5.3       Spain: Custom Antibody Market, by Type, 2019–2028 (USD Million)

12.1.2.5.4       Spain: Custom Antibody Market, by Source, 2019–2028 (USD Million)

12.1.2.5.5       Spain: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)

12.1.2.5.6       Spain: Custom Antibody Market, by End User, 2019–2028 (USD Million)

12.1.2.6       Rest of Europe: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.6.1       Rest of Europe: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)

12.1.2.6.2       Rest of Europe: Custom Antibody Market, by Service, 2019–2028 (USD Million)

12.1.2.6.3       Rest of Europe: Custom Antibody Market, by Type, 2019–2028 (USD Million)

12.1.2.6.4       Rest of Europe: Custom Antibody Market, by Source, 2019–2028 (USD Million)

12.1.2.6.5       Rest of Europe: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)

12.1.2.6.6       Rest of Europe: Custom Antibody Market, by End User, 2019–2028 (USD Million)

13.        Impact Of COVID-19 Pandemic on Europe Custom Antibody Market

13.1      Europe: Impact Assessment of COVID-19 Pandemic

14.        Industry Landscape

14.1      Overview

14.2      Growth Strategies Done by the Companies in the Market, (%)

14.3      Inorganic Growth Strategies

14.3.1     Overview

14.4      Organic Growth Strategies

14.4.1     Overview

15.        COMPANY PROFILES

15.1      THERMO FISHER SCIENTIFIC INC.

15.1.1     Key Facts

15.1.2     Business Description

15.1.3     Products and Services

15.1.4     Financial Overview

15.1.5     SWOT Analysis

15.1.6     Key Developments

15.2      BIO-RAD LABORATORIES INC.

15.2.1     Key Facts

15.2.2     Business Description

15.2.3     Products and Services

15.2.4     Financial Overview

15.2.5     SWOT Analysis

15.2.6     Key Developments

15.3      MERCK KGaA

15.3.1     Key Facts

15.3.2     Business Description

15.3.3     Products and Services

15.3.4     Financial Overview

15.3.5     SWOT Analysis

15.3.6     Key Developments

15.4      ABCAM

15.4.1     Key Facts

15.4.2     Business Description

15.4.3     Products and Services

15.4.4     Financial Overview

15.4.5     SWOT Analysis

15.4.6     Key Developments

15.5      GenScript

15.5.1     Key Facts

15.5.2     Business Description

15.5.3     Products and Services

15.5.4     Financial Overview

15.5.5     SWOT Analysis

15.5.6     Key Developments

15.6      Agilent Technologies, Inc.

15.6.1     Key Facts

15.6.2     Business Description

15.6.3     Products and Services

15.6.4     Financial Overview

15.6.5     SWOT Analysis

15.6.6     Key Developments

15.7      Cell Signaling Technology, Inc.

15.7.1     Key Facts

15.7.2     Business Description

15.7.3     Products and Services

15.7.4     Financial Overview

15.7.5     SWOT Analysis

15.7.6     Key Developments

16.        Appendix

16.1      About the Insight Partners

16.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             UK: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 2.             UK: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             UK: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)

Table 4.             UK: Custom Antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)

Table 5.             UK: Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 6.             Germany: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 7.             Germany: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             Germany: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)

Table 9.             Germany: Custom Antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)

Table 10.          Germany: Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 11.          France: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 12.          France: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 13.          France: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)

Table 14.          France: Custom Antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)

Table 15.          France: Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 16.          Italy: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 17.          Italy: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 18.          Italy: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)

Table 19.          Italy: Custom Antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)

Table 20.          Italy: Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 21.          Spain: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 22.          Spain: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 23.          Spain: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)

Table 24.          Spain: Custom Antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)

Table 25.          Spain: Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 26.          Rest of Europe: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)

Table 27.          Rest of Europe: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)

Table 28.          Rest of Europe: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)

Table 29.          Rest of Europe: Custom Antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)

Table 30.          Rest of Europe: Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 31.          Recent Inorganic Growth Strategies in the Custom Antibody Market

Table 32.          Recent Organic Growth Strategies in the Custom Antibody Market

Table 33.          Glossary of Terms, Custom Antibody Market

 


LIST OF FIGURES

Figure 1.           Custom Antibody Market Segmentation

Figure 2.           Europe Custom Antibody Market Overview

Figure 3.           Antibody Development Segment Held Largest Share of Service in Custom Antibody Market

Figure 4.           UK is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Custom Antibody Market - Europe PEST Analysis

Figure 6.           Custom Antibody Market Impact Analysis of Driver and Restraints

Figure 7.           Europe Custom Antibody Market – Revenue Forecasts and Analysis – 2020- 2028

Figure 8.           Custom Antibody Market Revenue Share, by Service (2020 and 2028)

Figure 9.           Antibody Development: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)

Figure 10.        Antibody Production and Purification: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Antibody Fragmentation and Labelling: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Custom Antibody Market Revenue Share, by Type (2020 and 2028)

Figure 13.        Monoclonal Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Polyclonal Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Other Custom Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Custom Antibody Market Revenue Share, by Source (2020 and 2028)

Figure 17.        Mice: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Rabbit: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Others: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Custom Antibody Market Revenue Share, by Research Area (2020 and 2028)

Figure 21.        Oncology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Immunology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Stem Cells: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Infectious Disease: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Neurobiology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Cardiovascular disease: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Others: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Custom Antibody Market Revenue Share, by End User (2020 and 2028)

Figure 29.        Pharmaceutical and Biotechnology Companies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Academic and Research Institutes: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Contract Research Organizations: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Europe: Custom Antibody Market, by Key Country – Revenue (2020) (USD Million)

Figure 33.        Europe: Custom Antibody Market , by Country, 2020 & 2028 (%)

Figure 34.        UK: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)

Figure 35.        Germany: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)

Figure 36.        France: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)

Figure 37.        Italy: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)

Figure 38.        Spain: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)

Figure 39.        Rest of Europe: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)

Figure 40.        Impact of COVID-19 Pandemic in European Country Markets

Figure 41.        Growth Strategies Done by the Companies in the Market, (%)

 

  1. Thermo Fisher Scientific Inc.
  2. Bio-Rad Laboratories Inc.
  3. Merck KGAA
  4. Abcam
  5. Genscript
  6. Agilent Technologies, Inc.
  7. Cell Signaling Technology, Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe custom antibody market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe custom antibody market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the custom antibody market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution.
TIPRE00023710
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing